These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 10468952

  • 21. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
    Hampl R, Snajderova M, Lebl J, Lisa L, Dvorakova M, Hill M, Sulcova J, Starka L.
    Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992
    [Abstract] [Full Text] [Related]

  • 22. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI, Omsjø IH, Hughes SC, Botta L, Hüls G, Holly JM, Lønning PE.
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [Abstract] [Full Text] [Related]

  • 23. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 24. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [Abstract] [Full Text] [Related]

  • 25. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 26. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin.
    Blok GJ, de Boer H, Gooren LJ, van der Veen EA.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):29-36. PubMed ID: 9302369
    [Abstract] [Full Text] [Related]

  • 27. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH, Hjerrild BE, Naeraa RW, Engbaek F, Mosekilde L, Christiansen JS.
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [Abstract] [Full Text] [Related]

  • 28. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome.
    Gravholt CH, Leth-Larsen R, Lauridsen AL, Thiel S, Hansen TK, Holmskov U, Naeraa RW, Christiansen JS.
    Eur J Endocrinol; 2004 Mar; 150(3):355-62. PubMed ID: 15012622
    [Abstract] [Full Text] [Related]

  • 29. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 30. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS.
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [Abstract] [Full Text] [Related]

  • 31. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [Abstract] [Full Text] [Related]

  • 32. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A, de Muinck Keizer-Schrama S, Stijnen T, Waelkens J, Wit JM, Vulsma T, Gerver WJ, Reeser H, Delemarre-van de Waal H, Jansen M, Drop S.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [Abstract] [Full Text] [Related]

  • 33. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
    Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS.
    Eur J Endocrinol; 1999 Dec; 141(6):601-8. PubMed ID: 10601963
    [Abstract] [Full Text] [Related]

  • 34. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 35. Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.
    Azziz R, Deal CL, Potter HD, Gargosky SE, Rosenfeld RG.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1747-51. PubMed ID: 7527410
    [Abstract] [Full Text] [Related]

  • 36. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
    Davis SR, Robinson PJ, Moufarege A, Bell RJ.
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):541-7. PubMed ID: 22106826
    [Abstract] [Full Text] [Related]

  • 37. So similar and so different: Circulating androgens and androgen origin in bulimic women.
    Naessén S, Söderqvist G, Carlström K.
    J Steroid Biochem Mol Biol; 2019 Jan; 185():184-188. PubMed ID: 30172682
    [Abstract] [Full Text] [Related]

  • 38. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels.
    Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH, Lamberts SW.
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):471-8. PubMed ID: 9640414
    [Abstract] [Full Text] [Related]

  • 39. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 40. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
    Teixeira RJ, Silva VC, Gazolla HM, Cunha SB, Guimarães MM.
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):69-75. PubMed ID: 11826868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.